Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants
Major depressive disorder (MDD) is a chronic relapsing psychiatric disorder. Conventional antidepressants usually require several weeks of continuous administration to exert clinically significant therapeutic effects, while about two-thirds of the patients are prone to relapse of symptoms or are com...
Saved in:
Main Authors: | Tao Chen (Author), Ling Cheng (Author), Jingwen Ma (Author), Jiyuan Yuan (Author), Chao Pi (Author), Linjin Xiong (Author), Jinglin Chen (Author), Huiyang Liu (Author), Jia Tang (Author), Yueting Zhong (Author), Xiaomei Zhang (Author), Zerong Liu (Author), Ying Zuo (Author), Hongping Shen (Author), Yumeng Wei (Author), Ling Zhao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013) -
Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant
by: Yuan Wang, et al.
Published: (2021) -
Case report: Dezocine's rapid and sustained antidepressant effects
by: Han Wang, et al.
Published: (2024) -
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
by: Tomasz Cholewinski, et al.
Published: (2021) -
Effects of Antidepressants
Published: (2012)